Stereotaxis Reports 2022 Third Quarter Financial Results
10. November 2022 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Stereotaxis to Report Third Quarter Financial Results on November 10, 2022
20. Oktober 2022 09:05 ET
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis Receives St. Louis Mayor’s Innovation Award for 2022
03. Oktober 2022 09:16 ET
|
Stereotaxis, Inc.
ST. LOUIS, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced it was...
International Meeting of the Society for Cardiac Robotic Navigation to Showcase Stereotaxis Technology and Its Clinical Value
29. September 2022 09:07 ET
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 29, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced its...
Overland Park Regional Medical Center Extends Leadership in Robotic Treatment of Heart Rhythm Disorders with Plans for Second Stereotaxis System
13. September 2022 09:06 ET
|
Stereotaxis, Inc.
ST. LOUIS, Sept. 13, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that...
Stereotaxis Reports 2022 Second Quarter Financial Results
09. August 2022 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial...
Industry Veterans Join Stereotaxis Commercial Leadership Team as Company Advances Robust Innovation Pipeline
02. August 2022 09:06 ET
|
Stereotaxis, Inc.
ST. LOUIS, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the...
Stereotaxis to Report Second Quarter Financial Results on August 9, 2022
19. Juli 2022 09:00 ET
|
Stereotaxis, Inc.
ST. LOUIS, July 19, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will...
Stereotaxis Announces CE Mark Submission for Robotically Navigated MAGiC Ablation Catheter
11. Juli 2022 09:08 ET
|
Stereotaxis, Inc.
ST. LOUIS, July 11, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the CE Mark...
Journal of Atrial Fibrillation & Electrophysiology Publishes Special Issue Dedicated to Robotics in EP
06. Juni 2022 09:07 ET
|
Stereotaxis, Inc.
ST. LOUIS, June 06, 2022 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, announces the publication of a...